{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:12:06Z","timestamp":1761808326162,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81330011"],"award-info":[{"award-number":["81330011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10620-019-05917-8","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T14:10:55Z","timestamp":1572531055000},"page":"2140-2147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors"],"prefix":"10.1007","volume":"65","author":[{"given":"Xiaoyuan","family":"Bian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingkang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenrui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-0593","authenticated-orcid":false,"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"5917_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA A Cancer J Clin. 2018;68:7\u201330.","journal-title":"CA A Cancer J Clin"},{"key":"5917_CR2","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1200\/JCO.2008.20.7753","volume":"27","author":"SF Altekruse","year":"2009","unstructured":"Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27:1485\u20131491.","journal-title":"J Clin Oncol"},{"key":"5917_CR3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u2013E386.","journal-title":"Int J Cancer"},{"key":"5917_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3322\/caac.21349","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271\u2013289.","journal-title":"CA Cancer J Clin"},{"key":"5917_CR5","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","volume":"64","author":"CE DeSantis","year":"2014","unstructured":"DeSantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64:252\u2013271.","journal-title":"CA Cancer J Clin"},{"key":"5917_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00432-015-1979-1","volume":"141","author":"SH Chien","year":"2015","unstructured":"Chien SH, Liu CJ, Hong YC, et al. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study. J Cancer Res Clin Oncol. 2015;141:1995\u20132004.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5917_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/ijc.29433","volume":"137","author":"SH Chien","year":"2015","unstructured":"Chien SH, Liu CJ, Hu YW, et al. Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: a nationwide population-based study. Int J Cancer. 2015;137:658\u2013665.","journal-title":"Int J Cancer"},{"key":"5917_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1477-7819-12-73","volume":"12","author":"L-C Sun","year":"2014","unstructured":"Sun L-C, Tai Y-Y, Liao S-M, et al. Clinical characteristics of second primary cancer in colorectal cancer patients: the impact of colorectal cancer or other second cancer occurring first. World J Surg Oncol. 2014;12:73.","journal-title":"World J Surg Oncol"},{"key":"5917_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/bjh.14530","volume":"177","author":"N Baras","year":"2017","unstructured":"Baras N, Dahm S, Haberland J, et al. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990\u20132012). Br J Haematol. 2017;177:226\u2013242.","journal-title":"Br J Haematol"},{"key":"5917_CR10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamaoncol.2017.3605","volume":"4","author":"CC Murphy","year":"2018","unstructured":"Murphy CC, Gerber DE, Pruitt SL. Prevalence of prior cancer among persons newly diagnosed with cancer: an initial report from the surveillance, epidemiology, and end results program. JAMA Oncol. 2018;4:832\u2013836. \nhttps:\/\/doi.org\/10.1001\/jamaoncol.2017.3605\n\n.","journal-title":"JAMA Oncol"},{"key":"5917_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/bjc.2017.27","volume":"116","author":"SL Pruitt","year":"2017","unstructured":"Pruitt SL, Laccetti AL, Xuan L, Halm EA, Gerber DE. Revisiting a longstanding clinical trial exclusion criterion: impact of prior cancer in early-stage lung cancer. Br J Cancer. 2017;116:717\u2013725.","journal-title":"Br J Cancer"},{"key":"5917_CR12","doi-asserted-by":"publisher","unstructured":"Laccetti AL, Pruitt SL, Xuan L, Halm EA, DE Gerber. Effect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual. J Natl Cancer Inst. 2015;107. \nhttps:\/\/doi.org\/10.1093\/jnci\/djv002\n\n.","DOI":"10.1093\/jnci\/djv002"},{"key":"5917_CR13","doi-asserted-by":"publisher","first-page":"7339","DOI":"10.18632\/oncotarget.3129","volume":"6","author":"QG Li","year":"2015","unstructured":"Li QG, Gan L, Liang L, Li XX, Cai SJ. The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer. Oncotarget. 2015;6:7339\u20137347.","journal-title":"Oncotarget"},{"key":"5917_CR14","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.1111\/bju.13144","volume":"117","author":"KT Dinh","year":"2016","unstructured":"Dinh KT, Mahal BA, Ziehr DR, et al. Risk of prostate cancer mortality in men with a history of prior cancer. BJU Int. 2016;117:E20\u2013E28.","journal-title":"BJU Int"},{"key":"5917_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.lungcan.2016.05.029","volume":"98","author":"AL Laccetti","year":"2016","unstructured":"Laccetti AL, Pruitt SL, Xuan L, Halm EA, Gerber DE. Prior cancer does not adversely affect survival in locally advanced lung cancer: a national SEER-medicare analysis. Lung Cancer (Amsterdam, Netherlands). 2016;98:106\u2013113.","journal-title":"Lung Cancer (Amsterdam, Netherlands)"},{"key":"5917_CR16","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/cncr.29200","volume":"121","author":"C Sadler","year":"2015","unstructured":"Sadler C, Goldfarb M. Comparison of primary and secondary breast cancers in adolescents and young adults. Cancer. 2015;121:1295\u20131302.","journal-title":"Cancer"},{"key":"5917_CR17","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.clcc.2015.11.003","volume":"15","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Tarazona N, Peckitt C, et al. Exclusion of gastrointestinal cancer patients with prior cancer from clinical trials: is this justified? Clin Colorectal Cancer. 2016;15:e53\u2013e59.","journal-title":"Clin Colorectal Cancer"},{"key":"5917_CR18","first-page":"180","volume":"76","author":"PP Varty","year":"1994","unstructured":"Varty PP, Delrio P, Boulos PB. Survival in colorectal carcinoma associated with previous extracolonic cancer. Ann R Coll Surg Engl. 1994;76:180\u2013184.","journal-title":"Ann R Coll Surg Engl"},{"key":"5917_CR19","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/annonc\/mdq078","volume":"21","author":"RK Pandurengan","year":"2010","unstructured":"Pandurengan RK, Dumont AG, Araujo DM, et al. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol Off J Eur Soc Med Oncol. 2010;21:2107\u20132111.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"5917_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/10428190802645061","volume":"50","author":"D Pulte","year":"2009","unstructured":"Pulte D, Gondos A, Brenner H. Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma. 2009;50:179\u2013186.","journal-title":"Leuk Lymphoma"},{"key":"5917_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/thx.2005.051615","volume":"62","author":"A Lopez-Encuentra","year":"2007","unstructured":"Lopez-Encuentra A, Gomez de la Camara A, Rami-Porta R, Duque-Medina JL, de Nicolas JL, Sayas J. Previous tumour as a prognostic factor in stage I non-small cell lung cancer. Thorax. 2007;62:386\u2013390.","journal-title":"Thorax"},{"key":"5917_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/BF01888509","volume":"17","author":"M Kanematsu","year":"1992","unstructured":"Kanematsu M, Imaeda T, Yamawaki Y, et al. Hepatocellular carcinoma with extrahepatic primary neoplasms. Gastrointest Radiol. 1992;17:53\u201357.","journal-title":"Gastrointest Radiol"},{"key":"5917_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2407-12-148","volume":"12","author":"QA Zeng","year":"2012","unstructured":"Zeng QA, Qiu J, Zou R, et al. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study. BMC Cancer. 2012;12:148.","journal-title":"BMC Cancer"},{"key":"5917_CR24","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/j.1440-1746.2009.05793.x","volume":"24","author":"M Fern\u00e1ndez-Ruiz","year":"2009","unstructured":"Fern\u00e1ndez-Ruiz M, Guerra-Vales J-M, Castelb\u00f3n-Fern\u00e1ndez F-J, Llenas-Garc\u00eda J, Caurcel-D\u00edaz L, Colina-Ruizdelgado F. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: analysis of a hospital-based tumor registry. J Gastroenterol Hepatol. 2009;24:1424\u20131430.","journal-title":"J Gastroenterol Hepatol"},{"key":"5917_CR25","doi-asserted-by":"publisher","first-page":"e3491","DOI":"10.1097\/MD.0000000000003491","volume":"95","author":"W Xu","year":"2016","unstructured":"Xu W, Liao W, Ge P, et al. Multiple primary malignancies in patients with hepatocellular carcinoma: a largest series with 26-year follow-up. Medicine. 2016;95:e3491.","journal-title":"Medicine"},{"key":"5917_CR26","doi-asserted-by":"publisher","unstructured":"Gerber DE, Laccetti AL, Xuan L, Halm EA and Pruitt SL. Impact of prior cancer on eligibility for lung cancer clinical trials. J Natl Cancer Inst. 2014;106. \nhttps:\/\/doi.org\/10.1093\/jnci\/dju302\n\n.","DOI":"10.1093\/jnci\/dju302"},{"key":"5917_CR27","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1200\/JCO.2017.73.7916","volume":"35","author":"ES Kim","year":"2017","unstructured":"Kim ES, Bruinooge SS, Roberts S, et al. Broadening eligibility criteria to make clinical trials more representative: American Society of clinical oncology and friends of cancer research joint research statement. J Clin Oncol Off J Am Soc Clin Oncol. 2017;35:3737\u20133744.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5917_CR28","doi-asserted-by":"publisher","first-page":"e7589","DOI":"10.1097\/MD.0000000000007589","volume":"96","author":"GS Zhao","year":"2017","unstructured":"Zhao GS, Liu Y, Zhang Q, et al. Transarterial chemoembolization combined with Huaier granule for the treatment of primary hepatic carcinoma: safety and efficacy. Medicine. 2017;96:e7589.","journal-title":"Medicine"},{"key":"5917_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1470-2045(12)70490-4","volume":"14","author":"A Santoro","year":"2013","unstructured":"Santoro A, Rimassa L, Borbath I, et al. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study. Lancet Oncol. 2013;14:55\u201363.","journal-title":"Lancet Oncol"},{"key":"5917_CR30","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1002\/cncr.30816","volume":"123","author":"G Kasuya","year":"2017","unstructured":"Kasuya G, Kato H, Yasuda S, et al. Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials. Cancer. 2017;123:3955\u20133965.","journal-title":"Cancer"},{"key":"5917_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","volume":"10","author":"AL Cheng","year":"2009","unstructured":"Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25\u201334.","journal-title":"Lancet Oncol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05917-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05917-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:19:35Z","timestamp":1603930775000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05917-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5917"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05917-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}